Cancer Immunotherapy Field Discussed by Kuick Research in Discounted Study Published at

05 Aug 2014 • by Natalie Aster

LONDON – Cancer immunotherapy has emerged in the recent past as a more efficient and less toxic therapeutic alternative for patients. The market availability of novel cancer immunotherapy agents has enabled the pharma companies to develop vital novel combined approaches to the treatment of diseases like renal cell carcinoma, colon cancer, bladder cancer and some leukemias, which are capable of providing much greater insight into the human body’s immune system. Cancer immunotherapy is forecast to continue to overflow with considerable potential as a result of a growing number of novel techniques and discoveries. However, despite the advancements being made regarding the understanding of the immune system’s complexities, there is still a lot more work to be done. The complete granular understanding is yet to be unraveled, which is one of the main reasons why cancer immunotherapy is not being in high use. 

To date, there are 605 cancer monoclonal antibodies, 289 cancer vaccines, 40 oncolytic viruses drugs, 82 cell therapies and 64 cytokine therapies are in clinical development pipeline.

Discounted research report “Cancer Immunotherapy Market & Clinical Pipeline Insight” drawn up by Kuick Research provides a comprehensive overview the cancer immunotherapy market landscape and dynamics. The study covers 1080 drugs in clinical pipeline, cancer monoclonal antibodies in clinical development (by phase and country), clinical pipeline for cancer vaccines (by phase and country), clinical trials of oncolytic viruses (by phase and country), insights into cancer cytokine therapy clinical pipeline (by phase and country), cancer cell therapy clinical pipeline review (by phase and country).

Report Details:

Cancer Immunotherapy Market & Clinical Pipeline Insight
Published: July, 2014
Pages: 1990
Price: US$ 3,600.00

Other Topical Life Sciences Markets Reports by Kuick Research:

More discounted and new studies by the publisher can be found at Kuick Research page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970